Fulgent Genetics, Inc.FLGTNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+84.1%
5Y CAGR+2.2%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+84.1%/yr
vs -4.3%/yr prior
5Y CAGR
+2.2%/yr
Recent acceleration
Acceleration
+88.4pp
Accelerating
Percentile
P90
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 50.45% |
| Q3 2025 | -9.57% |
| Q2 2025 | 14.58% |
| Q1 2025 | -0.36% |
| Q4 2024 | 12.65% |
| Q3 2024 | 0.51% |
| Q2 2024 | -1.83% |
| Q1 2024 | -27.79% |
| Q4 2023 | 52.59% |
| Q3 2023 | -3.68% |
| Q2 2023 | -9.94% |
| Q1 2023 | -18.34% |
| Q4 2022 | 8.09% |
| Q3 2022 | -12.12% |
| Q2 2022 | 21.92% |
| Q1 2022 | 11.26% |
| Q4 2021 | 65.49% |
| Q3 2021 | 35.16% |
| Q2 2021 | 4.14% |
| Q1 2021 | 2.27% |
| Q4 2020 | 45.30% |
| Q3 2020 | 73.06% |
| Q2 2020 | 39.29% |
| Q1 2020 | 7.87% |
| Q4 2019 | 4.92% |
| Q3 2019 | 9.34% |
| Q2 2019 | 4.78% |
| Q1 2019 | 11.82% |
| Q4 2018 | 3.47% |
| Q3 2018 | -8.47% |
| Q2 2018 | 1.07% |
| Q1 2018 | 9.04% |
| Q4 2017 | -7.26% |
| Q3 2017 | 29.98% |
| Q2 2017 | -16.24% |
| Q1 2017 | 24.19% |
| Q4 2016 | -6.18% |
| Q3 2016 | 118.42% |
| Q2 2016 | -57.35% |
| Q1 2016 | -43.41% |